CAMBRIDGE, Mass., November 04, 2024--2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held ...
9h
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research ...
The companies’ CAR-T seemed to cause fewer movement disorders in a multiple myeloma trial than J&J's Carvykti has in other ...
Azenta, Inc. will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes. The Company will host a ...
When it comes to keeping your smile bright and healthy, MySmile offers a complete range of effective, affordable, and safe oral care products. With over 10,000 5-star reviews on Amazon and TikTok, ...
Bristol-Myers Squibb (BMY) stock gained as the comany exceeded Q3 2024 financial forecasts, with strong revenue growth and ...
2seventy bio-partnered Abecma (idecabtagene vicleucel) is already approved as a fourth-line or later therapy for the blood cancer, and the KarMMa-3 study is designed to support second or third ...
The study – which tested Carvykti in patients with one to three lines of prior therapy – gives J&J an opportunity to leapfrog Bristol-Myers Squibb and 2Seventy bio's rival BCMA CAR-T therapy ...
Tensions flared in Belagavi, Karnataka, after a poster depicting Mughal emperor Aurangzeb as the "real founder of Akhand Bharat" was removed by police. The poster, installed by unidentified youths ...
United Statescategory Michigan city of Warren in focus amid worries about delayed election results November 2, 2024 United Statescategory Harris and Trump locked in tight race in swing states, NYT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback